Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-21-000060

Principal Accounting Officer sold 1,777 shares at $61.61 ($109,481)

  • Principal Accounting Officer acquired 1,777 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Alenson Carman · Principal Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-21 Exercise or conversion : show line 1 in the form +1,777 $51.51 $91,533 1,777 D
2021-06-21 Sale : show line 2 in the form −1,777 $61.61 $109,481 0 D
Open-market sales · 1,777 sh · avg $61.61 · $109,481

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-21 Exercise or conversion : show line 3 in the form Stock option (right to buy) −1,777 3,555 D
Loading xslF345X03/wf-form4_162448370684332.xml…